Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection

Journal of Surgical Oncology

Volumn 95, Issue 4, 2007, Pages 298-303

  Zhou, Li ^a   Rui, Jing An ^a   Wang, Shao Bin ^a   Chen, Shu Guang ^a   Qu, Qiang ^a   Chi, Tian Yi ^a   Wei, Xue ^a   Han, Kai ^a   Zhang, Ning ^a   Zhao, Hai Tao ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Curative hepatic resection; Female; Hepatocellular carcinoma; Male; Prognostic factor

Indexed keywords

ALPHA FETOPROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR THROMBUS; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VENOUS THROMBOSIS;

EID: 33847610604     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20678     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, et al.: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156.
2. Kubicka S, Rudolph KL, Hanke M, et al.: Hepatocellular carcinoma in Germany: A retrospective epidemiological study from a low-endemic area. Liver 2000;20:312-318.
3. Lee CM, Lu SN, Changchien CS, et al.: Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 1999;86:1143-1150.
4. Ng IO, Lai EC, Ng MM, et al.: Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 1992; 70:45-49.
5. Eagon PK, Francavilla A, DiLeo A, et al.: Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver. Dig Dis Sci 1991;36:1303-1308.
6. Poon RT, Fan ST, Lo CM, et al.: Improving survival results after resection of hepatocellular carcinoma: A prospective study of 377 patients over 10 years. Ann Surg 2001;234:63-70.
7. Shimozawa N, Hanazaki K: Longterm prognosis after hepatic-resection for small hepatocellular carcinoma. J Am Coll Surg 2004;198:356-365.
8. Hanazaki K, Kajikawa S, Koide N, et al.: Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: Univariate and multivariate analysis. Am J Gastroenterol 2001;96:1243-1250.
9. Hanazaki K, Kajikawa S, Shimozawa N, et al.: Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm. Hepatogastroenterology 2002;49:518-523.
10. Hu RH, Lee PH, Chang YC, et al.: Prognostic factors for hepatocellular carcinoma < or = 3 cm in diameter. Hepatogastroenterology 2003;50:2043-2048.
11. Hermanek P, Sobin LH: TNM classification of malignant tumors. Berlin: Springer, 1992: pp 104-112.
12. Edmondson HA, Steiner PE: Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 1954;7: 462-503.
13. Lee CC, Chau GY, Lui WY, et al.: Better post-resectional survival in female cirrhotic patients with hepatocellular carcinoma. Hepatogastroenterology 2000;47:446-449.
14. Dohmen K, Shigematsu H, Irie K, et al.: Longer survival in female than male with hepatocellular carcinoma. J Gastroenterol Hepatol 2003;18:267-272.
15. Lam CM, Yong JL, Chan AO, et al.: Better survival in female patients with hepatocellular carcinoma: Oral contraceptive pills related? J Clin Gastroenterol 2005;39:533-539.
16. Wayne JD, Lauwers GY, Ikai I, et al.: Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 2002;235:722-730.
17. Fukuda S, Itamoto T, Nakahara H, et al.: Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology 2005; 52:1163-1167.
18. Kishimoto K, Fujimoto J, Takeuchi M, et al.: Telomerase activity in hepatocellular carcinoma and adjacent liver tissues. J Surg Oncol 1998;69:119-124.
19. Ng IO, Lai EC, Fan ST, et al.: Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 1994;73:2268-2274.
20. Yeh CN, Chen MF, Lee WC, et al.: Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: Univariate and multivariate analysis. J Surg Oncol 2002;81:195-202.
21. Adachi E, Maeda T, Kajiyama K, et al.: Factors correlated with portal venous invasion by hepatocellular carcinoma: Univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer 1996;77;2022-2031.
22. Kubo S, Tanaka H, Shuto T, et al.: Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B. Surg Today 2005;35:216-222.
23. Nanashima A, Omagari K, Tobinaga S, et al.: Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis. Eur J Surg Oncol 2005;31:882-890.
24. Huang YH, Chen CH, Chang TT, et al.: Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. J Gastroenterol Hepatol 2005;20:765-771.
25. Peng SY, Chen WJ, Lai PL, et al.: High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer 2004;112: 44-50.
26. Wang XW, Xie H: Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro. Life Sci 1999;64:17-23.